Moreover, although inhibiting FASN expression decreases fatty acid levels in non–small-cell lung cancer, it paradoxically increases the ratio of LC3 II to LC3 I, thereby promoting autophagy (Yan et al, 2021). Here, FASN is linked to lung cancer.